Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Operating Expenses Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual operating expenses in 2023 was 982.41 Million JPY , up 25.26% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly operating expenses in 2024 Q1 was 241 Million JPY , up 5.89% from previous quarter.
  • Perseus Proteomics Inc. reported a annual operating expenses of 784.3 Million JPY in annual operating expenses 2022, up 45.26% from previous year.
  • Perseus Proteomics Inc. reported a annual operating expenses of 539.94 Million JPY in annual operating expenses 2021, up 13.47% from previous year.
  • Perseus Proteomics Inc. reported a quarterly operating expenses of 232.15 Million JPY for 2023 Q2, down -9.95% from previous quarter.
  • Perseus Proteomics Inc. reported a quarterly operating expenses of 257.81 Million JPY for 2023 Q1, up 6.39% from previous quarter.

Annual Operating Expenses Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Operating Expenses of Perseus Proteomics Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 982.41 Million JPY 25.26%
2022 784.3 Million JPY 45.26%
2021 539.94 Million JPY 13.47%
2020 475.84 Million JPY -48.22%
2019 919 Million JPY 0.0%

Peer Operating Expenses Comparison of Perseus Proteomics Inc.

Name Operating Expenses Operating Expenses Difference
Kyowa Kirin Co., Ltd. 224.77 Billion JPY 99.563%
Astellas Pharma Inc. 1034.29 Billion JPY 99.905%
Chugai Pharmaceutical Co., Ltd. 258.88 Billion JPY 99.621%
Ono Pharmaceutical Co., Ltd. 212.44 Billion JPY 99.538%
Santen Pharmaceutical Co., Ltd. 111.97 Billion JPY 99.123%
JCR Pharmaceuticals Co., Ltd. 23.72 Billion JPY 95.858%
Daiichi Sankyo Company, Limited 974.77 Billion JPY 99.899%
Otsuka Holdings Co., Ltd. 1115.15 Billion JPY 99.912%